26 August 2026ICE – משפט

Derivative Lawsuit Filed Against Tomer Mazon Over Inventory Discrepancies

Legal and stock market drama surrounds Tomer Mazon: A NIS 2.5 million derivative lawsuit was filed against its controlling shareholder and board, alleging misleading inventory disclosures. This follows a Securities Authority investigation and trading halt sparked by a sudden resignation of a designated CFO and reporting ambiguities.

Source transparency

This is an original newsroom summary and analysis. The source was not reproduced, and readers can inspect the original publication.

Original publication at ICE – משפט

Why it matters

The affair underscores the risks associated with inventory reporting and shell company mergers, highlighting the importance of Securities Authority oversight and the maintenance of proper corporate governance to protect investors.

Key points

  • ▪A derivative lawsuit of NIS 2.5 million was filed against Tomer Mazon and its officers.
  • ▪The lawsuit includes allegations of misrepresentations regarding the company's inventory valuations.
  • ▪Trading in the company's stock was halted by the Stock Exchange due to ambiguity in financial appointments.
  • ▪The Securities Authority has launched an investigation to examine inventory reports and public disclosures.
  • ▪The company was required to update its reports after a designated CFO refused to take the position.

A legal and regulatory storm is brewing around the Israeli food giant 'Tomer Mazon'. Recent reports indicate that a derivative lawsuit for NIS 2.5 million has been filed with the Tel Aviv District Court's Economic Department against the company, controlling shareholder Doron Kimelov, and members of the board. The lawsuit, filed by a company shareholder, presents serious allegations regarding the conduct of the officers. It is alleged that the company made misrepresentations and breached its fiduciary duties during the merger process of the private entity into a public shell company.

In the claim, the plaintiff argues that misleading and inflated valuations of the company's inventory were presented. Furthermore, it is alleged that the merger was approved in haste without proper due diligence, while excessive consideration was transferred to the controlling shareholder. Additionally, it was claimed that the board of directors was fully controlled by Kimelov and his associates, and that the company failed to appoint a professional CFO for an extended period.

The company’s legal difficulties occur alongside deep instability in the capital market. The Tel Aviv Stock Exchange board recently ordered a trading halt on the company's stock, following the decision of the designated CFO, Avital Pearlstein Cherny, not to take the position. According to reports, Tomer Mazon initially claimed that this was a matter not requiring special disclosure, but later had to update that the resignation was related to the handling of a subsidiary's inventory in previous years. The company's reports are now under a comprehensive review by the Securities Authority, which seeks to clarify the true state of the inventory and the nature of the disclosures provided to the investing public.

The allegations detailed in the statement of claim have not yet been adjudicated in court, and the legal proceeding is in its early stages. For shareholders and stock market investors, the case highlights the critical importance of transparency in inventory reporting and proper corporate governance processes in mergers with public shells.

General information only. This item is not legal advice and does not replace review of the original source.

Back to all legal news

LawFirms.pro

Update or Remove Public Information

LawFirms.pro allows lawyers and the public to submit requests to update, correct, or remove public information for manual review.

Update or Remove Profile